X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $87,486.13 -0.39%
Ethereum $2,930.61 -0.51%
BNB $852.64 -1.29%
Optimism $0.27 -1.42%
Arbitrum $0.19 -3.00%
Solana $123.34 -0.96%
Polygon $0.22 +2.77%
Cosmos $2.00 -4.10%
Avalanche $12.60 -0.81%

Bitcoin $87,486.13 -0.39%
Ethereum $2,930.61 -0.51%
BNB $852.64 -1.29%
Optimism $0.27 -1.42%
Arbitrum $0.19 -3.00%
Solana $123.34 -0.96%
Polygon $0.22 +2.77%
Cosmos $2.00 -4.10%
Avalanche $12.60 -0.81%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed